Navigation Links
US Patent Office Grants McCord Research Endothelial Cell Treatment Patent
Date:7/21/2014

CORALVILLE, Iowa, July 21, 2014 /PRNewswire/ -- McCord Research, Inc. was recently granted a second US patent (U.S. Patent No. 8,796,315). This patent describes a method for accelerating wound closure to improve wound healing.  According to the inventor, Dr. McCord, this method includes administering or transplanting to individuals who require wound healing, a composition of an effective amount of hydroxytyrosol and oleuropein and cells derived from umbilical cord blood, such that the administration of the combination reduces the time required for wound healing by at least approximately 30% in comparison to treatment with just cells derived from umbilical cord blood alone.

Endothelial cells form the inner lining of a blood vessel and provides an anticoagulant barrier between the vessel wall and blood. Endothelial cells have a vital role in wound repair especially for patients with vascular disease and diabetes.  The restoration of these cells allows for vital nutrients to be delivered to the skin and wound through the small network of capillaries that form at the dermal epidermal junction. The endothelial cells additionally regulate hemostasis, vasomotor tone, angiogenesis and vasculogenesis and immune and inflammatory responses. In addition, the endothelial cell plays a pivotal role in wound care. "Endothelial cell injury is the genesis of many pathologic states including atherosclerosis, loss of semi-permeable membrane function, and thrombosis. Restoring the viability of endothelial cells has far reaching health implications," stated Dr. McCord.

McCord Research is seeking worldwide patent protection for its wound care technology and looks forward to healing wounds on a global basis. The technology is currently being licensed under the Olivamine 10® brand name in the United States and Asia for the treatment of wounds in humans and animals.

McCord Research, Inc. corporate offices are located at 2769 Heartland Drive in Coralville, IA.
For further information call 319-358-5536 or www.mccordresearch.com.  

www.olivamine.com
www.mccordresearch.com
www.facebook.com/mccordresearch

For Further Information:
Darlene McCord, Ph.D., CEO, CSO
McCord Research/Pinnaclife, Inc.
inquire@mccordresearch.com
319-351-3201

Logo - http://photos.prnewswire.com/prnh/20120510/CG05130LOGO


'/>"/>
SOURCE McCord Research, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents
2. BMC to Actively Defend against Curative in Patent Fight
3. Columbia Laboratories Expands its Intellectual Property Portfolio Following Receipt of U.S. Patent
4. The Medicines Patent Pool Signs a Record Seven New Sub-Licences to Speed the Availability of Generic HIV Medicines to Developing Countries
5. Diomics Announces Issuance Of U.S. Patents For Novel Biologic Sample DNA Collection Materials For Use In Forensics And Diagnostics
6. MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics
7. Fuisz Pharma LLC Announces Patent Filing for Novel System and Method to Obtain Blood for Diagnostic Analysis Using a Lancet or Needle Puncture
8. CorMedix Awarded European Patent for Neutrolin
9. Puritan Medical Products erhält zwei neue Patente für beflockte Tupfer in Japan
10. Puritan Medical Products Recebe Duas Novas Patentes Swab com Algodão no Japão
11. Puritan Medical Products Awarded Two New Flocked Swab Patents in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire/ ... with cutting edge next-generation sequencing and bioinformatics expertise; AITbiotech Pte ... the Genome Institute of Singapore (GIS) ... joint venture between Novogene and AITbiotech – will establish a ... Singapore .   The new centre will ...
(Date:12/8/2016)... -- Eli Lilly and Company (NYSE: LLY ... a cyclin-dependent kinase (CDK) 4 and CDK 6 inhibitor, ... a biomarker of cell proliferation, after two weeks of ... during the official press program at the 2016 San ... or in combination with the non-steroidal aromatase-inhibitor anastrozole, in ...
(Date:12/7/2016)... Dec. 7, 2016 KEY FINDINGS ... benefits such as reducing loss of blood during ... cardiac arrests, rapid recovery after surgeries, and decreasing ... be segmented into convective warming system, surface warming ... turn reduce the stay at hospitals thus, lowering ...
Breaking Medicine Technology:
(Date:12/8/2016)... Reston, Virginia (PRWEB) , ... December 08, 2016 ... ... and services company offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient ... of operations and general counsel and Eric Hoessel to vice president of sales. ...
(Date:12/8/2016)... ... , ... Premier Fitness Camp (PFC) and The Chopra Center for Wellbeing announced ... program, at their world headquarters of Omni La Costa Resort & Spa in San ... seeking weight loss, personal development, a healthy lifestyle, or mental and physical healing. The ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Medical Center has been recognized for adherence to the highest standards of ... medical accreditation organizations, announced the center's president and CEO, Dr. Daniel Messina. , ...
(Date:12/8/2016)... NC (PRWEB) , ... December 08, 2016 , ... ... Medicare and the Affordable Care Act. Dr. Botelho advocates for the mass media ... story movement gives people ongoing opportunities to share their unfortunate experiences; such a ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... services from offices headquartered in Jefferson County, is announcing the launch of a ... Birmingham. , The number of homeless women and children in Birmingham has grown ...
Breaking Medicine News(10 mins):